The Management of Pneumonia Diseases in Children Underfive at Sekou Toure Regional Hospital.

Mapunda, Osmund CUHAS/MD/4000519/T/10

The Management of Pneumonia Diseases in Children Underfive at Sekou Toure Regional Hospital. - Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS – Bugando] : ©2015 - iii; 11 Pages Includes References

Abstract:

Pneumonia is an inflammatory condition of the lung affecting primarily the microscopic air sacs known as alveoli. It is usually caused by infection with viruses or bacteria and less commonly other microorganisms, certain drugs and other conditions such as autoimmune diseases.

Typical signs and symptoms include a cough, chest pain, fever, and difficulty breathing. Diagnostic tools include x-rays and culture of the sputum. Vaccines to prevent certain types of pneumonia are available. Treatment depends on the underlying cause. Pneumonia presumed to be bacterial is treated with antibiotics. If the pneumonia is severe, the effected person is generally hospitalized.

Pneumonia affects approximately 450 million people globally per year (7% of the population) and results in about 4 million deaths. Although pneumonia was regarded by William Osler in the 19th century as “captain of the men of death”[5] the advent of antibiotic therapy and vaccines in the 20th century has seen improvements in survival. [6] Nevertheless, in developing countries, and among the very old, the very young, and the chronically ill, pneumonia remains a leading cause of death. [6] In the terminally ill and elderly, especially those with other conditions, pneumonia is often the immediate cause of death. In such cases, particularly when it cuts short the suffering associated with lingering illness, pneumonia has often been called “the old man’s friend.”




P. O. Box 1464, Mwanza – Tanzania: Phone: +255 28 298 3384: Fax: +255 28 298 3386: Email: vc@bugando.ac.tz : www.bugando.ac.tz

--Pediatrics and Child Health
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024